SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-294455
Filing Date
2022-11-29
Accepted
2022-11-29 17:22:02
Documents
15
Period of Report
2022-11-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d374796d8k.htm   iXBRL 8-K 26834
2 EX-99.1 d374796dex991.htm EX-99.1 19998
6 GRAPHIC g374796g1130031820827.jpg GRAPHIC 2060
7 GRAPHIC g374796g1130031907426.jpg GRAPHIC 2110
  Complete submission text file 0001193125-22-294455.txt   176253

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20221129.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20221129_lab.xml EX-101.LAB 16429
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20221129_pre.xml EX-101.PRE 10370
9 EXTRACTED XBRL INSTANCE DOCUMENT d374796d8k_htm.xml XML 3174
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 221433714
SIC: 2834 Pharmaceutical Preparations